how long have glp 1 drugs been around Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Frontiers | GLP-1 receptor agonists:

Proteomics Clin Applications (2018) 12(1)

Both TNF- and MCP-1 promote evolution of atherosclerotic lesions and consequently their deficiency reduce those lesions

A recent study conducted on 41 diabetic patients demonstrated that exposure to the GLP-1 RA dulaglutide over a 48-week period was associated with a substantial decrease in non-butyrate-producing Firmicutes (e.g., Ruminococcus and Blautia ), accompanied by an increase in Bacteroides, Lactobacillus , and Prevotella (74)

The impact will also be felt more broadly within the healthcare sector

Patents And Regulatory Exclusivities On Inhalers For Asthma And COPD, 1986-2020

The timeline for feeling noticeably less hungry after starting Semaglutide is a gradual progression that aligns directly with your specific dosing schedule